IMM-H024

N/A

Report date: 2025/03/07 15:29:08
NME

Base Information

Drug NameIMM-H024
Drug Alias NameIMM-H024IMMH024
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK3 inhibitors
TargetsTyrosine-protein kinase JAK3
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInstitue Of Materia Medica Chinese Academy Of Medical Science
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesInstitue Of Materia Medica Chinese Academy Of Medical ScienceHunan Fangsheng Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A